[ARS] CUMBERLAND PHARMACEUTICALS INC SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

Analyzing...

03/12/2026 - 05:00 PM

ARS - CUMBERLAND PHARMACEUTICALS INC

ARS Filing - CUMBERLAND PHARMACEUTICALS INC

This filing is available as a PDF document.

Filing Type: ARS

Company: CUMBERLAND PHARMACEUTICALS INC (CPIX)

Acceptance Date: 2026-03-12T17:00:17.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Cumberland Pharmaceuticals Inc

NASDAQ:CPIX

View CPIX Stock Overview →

CPIX Rankings

#5660 Ranked by Market Cap

N/A Ranked by Dividends

CPIX Latest News

Mar 4, 2026

H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight

Mar 3, 2026

CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH

Feb 25, 2026

Joint U.S. Commercialization of RedHill's Talicia® Commences

Feb 25, 2026

CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA®

Feb 24, 2026

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE

CPIX Latest SEC Filings

Mar 9, 2026

[DEF 14A] CUMBERLAND PHARMACEUTICALS INC Definitive Proxy Statement

Mar 6, 2026

[10-K] CUMBERLAND PHARMACEUTICALS INC Files Annual Report

Mar 3, 2026

[8-K] CUMBERLAND PHARMACEUTICALS INC Reports Material Event

Feb 9, 2026

[SCHEDULE 13G] CUMBERLAND PHARMACEUTICALS INC Passive Investment Disclosure (>5%)

Feb 4, 2026

[8-K] CUMBERLAND PHARMACEUTICALS INC Reports Material Event

CPIX Stock Data

Market Cap 46.22M

Float 8.30M

Industry Drug Manufacturers - Specialty & Generic

Sector Pharmaceutical Preparations

Website Link

Country United States

City NASHVILLE,